‘Edarbi’ co-marketed by Takeda Pharmaceuticals & Dong-A ST enters Seoul National University Hospital

‘Edarbi’ jointly sold by Takeda Pharmaceuticals and Dong-A ST has entered Seoul National University Hospital.

At the Drug Committee on the last 2^nd, Seoul National University let various drugs, like ‘Edarbi.’ LG Chem’s ‘Zemiro,’ GC Pharm’s ‘IVIG-SN’ and Celltion’s ‘Herzuma,’ pass the committee.

When it comes to products which passed this Seoul National University Hospital’s Drug Committee, th...